Furthermore, control individuals with a higher risk of AD (CSF Aβ42/p-tau ratio < 6.5 combined with CSF T-tau > 350 ng/l) had elevated levels of MMP-9. The gene discussed is MAPT; the disease is Alzheimer disease.